⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15689797 | 1.00 | — | — | |
| Lactic Acid SCHEMBL31601684 | 0.78 | TP53 (0.92) | — | |
| Lactic Acid SCHEMBL3641296 | 0.78 | TP53 (0.92) | — | |
| Isopropyl Alcohol SCHEMBL538205 | 0.76 | TP53 (0.61) | — | |
| Bicarbonate SCHEMBL2159674 | 0.76 | — | — | |
| SCHEMBL28612 | 0.76 | — | — | |
| Isopropyl Alcohol SCHEMBL9737750 | 0.76 | — | — | |
| Isopropyl Alcohol SCHEMBL3155394 | 0.76 | TP53 (0.61) | — | |
| L-Lactic Acid SCHEMBL191421 | 0.75 | TP53 (0.50) | — | |
| Lactic Acid SCHEMBL10562978 | 0.75 | TP53 (0.85) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160022648-A1 | THERAPEUTIC AGENT FOR MEIBOMIAN GLAND DYSFUNCTION | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2016-01-28 | — | — | US | claimed |
| EP-2974728-A1 | THERAPEUTIC AGENT FOR MEIBOMIAN DYSFUNCTION | Santen Pharmaceutical Co., Ltd (JP) | 2016-01-20 | — | — | EP | claimed |
| CN-101654563-A | Crystalline polymer blend and molding product thereof | TORAY FIBER RES INST CN CO LTD | 2010-02-24 | — | — | CN | claimed |
| US-6080784-A | Protein kinase C modulators N | PROCYON PHARMACEUTICALS, INC. (US) | 2000-06-27 | — | — | US | claimed |
| JP-3008195-B2 | — | — | 2000-02-14 | — | — | JP | claimed |
| EP-0553107-B1 | PROTEIN KINASE C MODULATORS WITH ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY | PROCYON PHARM INC (US) | 1999-09-29 | — | — | EP | claimed |
| US-5955501-A | DERIVED FROM PHORBOIDS OF THE DITERPENE- AND BENZOLACTAM-CLASSES. | PROCYON PHARMACEUTICALS, INC. (US) | 1999-09-21 | — | — | US | claimed |
| US-5750568-A | DITERPENE PHORBOIDS | PROCYON PHARMACEUTICALS, INC. (US) | 1998-05-12 | — | — | US | claimed |
| US-5643948-A | ANTIINFLAMMATORY, ANTICANCER | PROCYON PHARMACEUTICALS, INC. (US) | 1997-07-01 | — | — | US | claimed |
| EP-0553107-A1 | PROTEIN KINASE C MODULATORS WITH ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY | PROCYON PHARMACEUTICALS, INC. (US) | 1993-08-04 | — | — | EP | claimed |
| EP-0310622-B1 | ANTI-INFLAMMATORY COMPOSITIONS | ALDER RESEARCH CENTER LIMITED PARTNERSHIP (US) | 1992-04-15 | — | — | EP | claimed |
| WO-1992002484-A1 | PROTEIN KINASE C MODULATORS WITH ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY | ALDER RESEARCH CENTER LIMITED PARTNERSHIP (US) | 1992-02-20 | — | — | WO | claimed |
| EP-0455271-A2 | Anti-inflammatory compositions | PROCYON PHARMACEUTICALS, INC. (US) | 1991-11-06 | — | — | EP | claimed |
| EP-0310622-A1 | ANTI-INFLAMMATORY COMPOSITIONS. | ALDER RES CENTER CORP (US) | 1989-04-12 | — | — | EP | claimed |
| WO-1987007599-A2 | ANTI-INFLAMMATORY COMPOSITIONS | ALDER RESEARCH CENTER CORPORATION (US) | 1987-12-17 | — | — | WO | claimed |
| JP-6031175-A | — | — | None | — | — | JP | disclosed |
| US-11951098-B2 | Therapeutic agent for meibomian dysfunction | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2024-04-09 | — | — | US | disclosed |
| EP-0133673-B1 | MEDICAMENTS CONTAINING VALEPOTRIATHYDRINES | Kali-Chemie Pharma GmbH (DE) | 1987-06-24 | — | — | EP | disclosed |
| US-4556737-A | ANTIALLERGENS, TREATMENT OF ASTHMA AND RHINITIS | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 1985-12-03 | — | — | US | disclosed |
| EP-0078026-A2 | Antibiotic synthesis | MERCK & CO. INC. (US) | 1983-05-04 | — | — | EP | disclosed |